METABOLIC ASPECTS OF ANTIHYPERTENSIVE TREATMENT WITH KETANSERIN

被引：9
作者：
FERRARA, LA
FASANO, ML
SORO, S
机构：
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1985年 / 7卷 / 05期
关键词：
D O I：
10.1097/00005344-198509000-00031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1007 / 1008
页数：2
相关论文
共 12 条
[1]   ELEVATION OF SERUM-LIPID LEVELS DURING DIURETIC THERAPY OF HYPERTENSION [J].
AMES, RP ;
HILL, P .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) :748-757
[2]   HYPERTENSION POTASSIUM ION AND IMPAIRED CARBOHYDRATE TOLERANCE [J].
CONN, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (21) :1135-&
[3]   EFFECT OF OXPRENOLOL AND METOPROLOL ON SERUM-LIPID CONCENTRATION [J].
FERRARA, LA ;
MAROTTA, T ;
SCILLA, A ;
MASTRANZO, P ;
STRAZZULLO, P ;
MANCINI, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (03) :331-334
[4]   CARDIOVASCULAR EFFECTS OF KETANSERIN, A NEW ANTISEROTONERGIC AGENT IN THE TREATMENT OF ARTERIAL-HYPERTENSION [J].
FERRARA, LA ;
FASANO, ML ;
SORO, S ;
RUBBA, P ;
IANNUZZI, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (03) :187-192
[5]  
FERRARA LA, 1979, GIORN ARTERIOSCLER, V4, P275
[6]  
HYELM M, 1966, SCAND J CLIN LAB INV, V18, P85
[7]  
LEREN P, 1980, LANCET, V2, P4
[8]  
LOPASVIRELLA MF, 1977, CLIN CHEM, V23, P882
[9]  
ORIENTE P, 1979, CLIN ENZYMOLOGY S, V2, P387
[10]   KETANSERIN IN ESSENTIAL-HYPERTENSION - EFFECTS DURING REST AND EXERCISE [J].
PERSSON, B ;
HEDNER, T ;
BERGLUND, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (03) :307-312
12